On August 13, Families USA sent this letter to Capitol Hill offering support for legislation to end “surprise billing,” along with specific recommendations for lawmakers as they consider legislation this fall.
Comments on Trump Administration Proposed Section 1557 Rules: Nondiscrimination in Health and Health Education Programs or Activities
Families USA submitted comments to urge HHS to withdraw the Trump administration’s proposed rule to undermine nondiscrimination protections under Section 1557 of the Affordable Care Act.
Families USA's Letter to Senators Grassley and Wyden on The Prescription Drug Pricing Reduction Act 2019
On Tuesday, July 23, 2019, the Senate Finance Committee announced the Prescription Drug Pricing Reduction Act of 2019, groundbreaking bipartisan legislation to improve the lives of millions of families in our country.
On July 15, Families USA sent this letter to Capitol Hill in support of H.R. 748, the Middle Class Health Benefits Tax Repeal Act of 2019, which will be considered by the full House of Representatives on July 17.
Families USA and 17 other consumer groups sent a letter to the House of Representatives urging passage of surprise bill legislation that fully protects consumers while preventing inflation in health care costs.
In this July 10, 2019 testimony before the House Committee on Oversight and Reform, Frederick Isasi, Executive Director at Families USA, discusses the disastrous effects on families across this nation if federal judges choose to strike down the Affordable Care Act in the Texas v. United States lawsuit.
Families USA submitted this letter in response to The Office of Management and Budget’s request for comment on how the various alternative consumer price indexes produced by the Bureau of Labor Statistics (BLS) and Bureau of Economic Analysis (BEA) would influence the estimation of the Official Poverty Measure (OPM).
In this June 18, 2019 testimony before the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP), Frederick Isasi, Executive Director at Families USA, discusses the Committee’s bipartisan draft legislation, the Lower Health Care Costs Act.
In this June 12, 2019 testimony before the U.S. House of Representatives Energy and Commerce Subcommittee on Health, Claire McAndrew, Director of Campaigns and Partnerships at Families USA, breaks down the problem with surprise medical bills and potential solutions under consideration by the committee.